Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening

Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening

The present investigation aims to examine the role of α-synuclein seed amplification assays for screening Parkinson’s disease. Parkinson’s disease (PD) is a debilitating neurodegenerative disorder caused by the loss of dopaminergic neurons in the midbrain, leading to symptoms such as tremors, bradyk...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alan D. Kaye, Kassady A. Perkinson, Noah J. Spillers, Alexis J. Vega, Caylin J. Roberts, Evan M. Downs, Melissa M. Sheth, David W. McGregor, Shahab Ahmadzadeh, Jibin Mathew, Sahar Shekoohi
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Current Issues in Molecular Biology
Subjects:	α-synuclein Parkinson’s disease screening seeding amplification assay
Online Access:	https://www.mdpi.com/1467-3045/46/11/757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review
by: Maria Bregendahl, et al.
Published: (2025-07-01)

Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
by: Stefan Bräuer, et al.
Published: (2025-01-01)

Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-11-01)

Prenatal Acetaminophen Exposure and its Associated Risk for Attention Deficit Hyperactivity Disorder
by: Noah J. Spillers, et al.
Published: (2024-11-01)

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
by: Chuchu Wang, et al.
Published: (2024-12-01)

Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
by: Jamir Pitton Rissardo, et al.
Published: (2025-06-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons
by: Plamena R. Angelova, et al.
Published: (2025-10-01)

The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
by: Yan Chen, et al.
Published: (2025-04-01)

USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells
by: Vignesh Srinivasan, et al.
Published: (2025-02-01)

Toward alpha‐synuclein seed amplification assay in clinical practice
by: Mathieu Verdurand, et al.
Published: (2025-01-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)

Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01)

Rektal Adenokarsinomlarda Aldehid Dehidrogenaz 1 ALDH1 ve Gamma Synuclein Ekspresyonunun Prognostik Değeri
by: Özlem Ata, et al.
Published: (2020-12-01)

A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
by: Dag Sehlin, et al.
Published: (2025-03-01)

Synthesis and preliminary biological evaluation of a novel PET tracer for α-synuclein PET imaging
by: WANG Ce, et al.
Published: (2024-10-01)

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)

Serum α-Synuclein in Pediatric Refractory Epilepsy: Correlation with Diagnosis and Clinical Severity
by: Aida M. S. Salem, et al.
Published: (2025-04-01)

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability
by: Elena A. Ostrakhovitch, et al.
Published: (2025-05-01)

An integrated machine learning approach delineates an entropic expansion mechanism for the binding of a small molecule to α-synuclein
by: Sneha Menon, et al.
Published: (2024-12-01)

Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
by: Emmanuel Quansah, et al.
Published: (2025-04-01)

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation
by: Jyutia Nargish, et al.
Published: (2025-04-01)

Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review
by: Alan D. Kaye, et al.
Published: (2025-06-01)

α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
by: Hung-Hsiang Ho, et al.
Published: (2024-11-01)

Correction: RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations
by: D. Koníčková, et al.
Published: (2025-06-01)

RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations
by: D. Koníčková, et al.
Published: (2025-05-01)

Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
by: Sonja Blumenstock, et al.
Published: (2017-03-01)

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
by: Lucia Lage, et al.
Published: (2025-03-01)

Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson’s disease
by: Maria Otero-Jimenez, et al.
Published: (2025-02-01)

THE LEVEL OF Α-SYNUCLEIN IN THE PLASMA AS A BIOMARKER OF PAIN IN PARKINSON'S DISEASE TAKING INTO ACCOUNT THE MOTOR SUBTYPES
by: K.A. Tarianyk
Published: (2024-07-01)

Dityrosine-Mediated Inhibition of α-Synuclein Fibrillation Using Photocatalytic Nanoparticles
by: Sonali Jena, et al.
Published: (2024-04-01)

α‐Synuclein Pathology Spreads in a Midbrain–Hindbrain Assembloid Model
by: Gemma Gomez‐Giro, et al.
Published: (2025-05-01)

Exploring the Potential of Biomimetic Peptides in Targeting Fibrillar and Filamentous Alpha-Synuclein—An In Silico and Experimental Approach to Parkinson’s Disease
by: Sophia A. Frantzeskos, et al.
Published: (2024-11-01)

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease
by: Guo Y, et al.
Published: (2016-02-01)

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01)

The effects of melatonin and catalase supplements on the survival of α-Synuclein-expressing saccharomyces cerevisiae cells.
by: Laura Houghton
Published: (2023-08-01)

Abnormal α-synuclein binds to synaptotagmin 13, impairing extracellular vesicle release in synucleinopathies
by: Yasuo Miki, et al.
Published: (2025-06-01)

Neuronal activity triggers secretory autophagy to mediate the extracellular release of SNCA/α-synuclein
by: Yoshitsugu Nakamura, et al.
Published: (2024-12-01)